Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study
Author:
Publisher
Elsevier BV
Subject
Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry
Reference53 articles.
1. Fight against novel coronavirus: a perspective of medicinal chemists;Amin;Eur. J. Med. Chem.,2020
2. A promising antiviral candidate drug for the COVID-19 pandemic: a mini-review of remdesivir;Liang;Eur. J. Med. Chem.,2020
3. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors;Zhang;Science,2020
4. COVID19 inhibitors: a prospective therapeutics;Akhtar;Bioorg. Chem,2020
5. Is oseltamivir suitable for fighting against COVID-19: in silico assessment, in vitro and retrospective study;Tan;Bioorg. Chem,2020
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An investigation on spectroscopic, wavefunction dependent reactivity, docking and anti-Covid-19 ability of flupentixol dihydrochloride: DFT and MD simulations at different temperatures;Journal of Molecular Liquids;2023-12
2. Recent advances in the piperazine based antiviral agents: A remarkable heterocycle for antiviral research;Arabian Journal of Chemistry;2023-12
3. Dihydrobenzothiazole coupled N‐piperazinyl acetamides as antimicrobial agents: Design, synthesis, biological evaluation and molecular docking studies;Archiv der Pharmazie;2023-11-30
4. A Molecular Docking Study: Benzoxazolone Derivatives against SARS-CoV-2 Omicron Subvariant EG.5.1;CHEM METHODOL;2023
5. Functionalization Strategies for Electropolishing Process of Carbon Steel Using Novel Quinazoline-4-one Derivatives: Synthesis, Spectroscopic Characterization, and DFT Studies;ACS Omega;2023-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3